Serum Endotoxin Activity Measured with Endotoxin Activity Assay Is Associated with Serum Interleukin-6 Levels in Patients on Chronic Hemodialysis
Authors:
- Enrico Di StasioESEnrico Di Stasio
- Maurizio SanguinettiMaurizio Sanguinetti
- Brunella PosteraroBrunella Posteraro
- Manuela AntociccoMAManuela Antocicco
- Gilda PepeGPGilda Pepe
- Enrica MelloEMEnrica Mello
- Francesca BugliFBFrancesca Bugli
- Carlo VulpioCVCarlo Vulpio
- 31 August 2016
- journal article
- research article
- Published by S. Karger AG in Blood Purification
- Vol. 42 (4) , 294-300
Abstract
Background: This study aims to evaluate, in patients on chronic hemodialysis (PHD), the levels of endotoxin through a chemiluminescent bioassay based on the oxidative burst reaction of activated neutrophils to complement coated LPS-IgM immune complexes and define the variables possibly correlated. Methods: In 61 PHD, we measured serum endotoxin activity (EA) with the Endotoxin Activity Assay (EAA™) and we defined the possible association with demographic, clinical and laboratory variables. Results: Mean serum EA was 0.43 ± 0.26 UI. EA was low (0.60) in 18 (29.5%). A significant exponential relationship was detected between EA and serum interleukin-6 (IL-6) levels (r = 0.871). At the multiple regression analysis, intermediate-high EA was directly associated only with serum IL-6 levels. In a second model of multiple regression analysis without the variable serum IL-6 levels, intermediate-high EA was directly associated with constipation and serum troponin levels and inversely associated with serum albumin and the monthly number of sevelamer tablets. Conclusions: A high percentage of PHD has intermediate or high EA. Intermediate-high EA is significantly associated with serum IL-6 levels.Keywords
This publication has 22 references indexed in Scilit:
- Gases as Uremic Toxins: Is There Something in the Air?Seminars in Nephrology, 2014
- A systematic review of stercoral perforationColorectal Disease, 2013
- Circulating bacterial-derived DNA fragments as a marker * of systemic inflammation in peritoneal dialysisNephrology Dialysis Transplantation, 2013
- Endotoxins and inflammation in hemodialysis patientsHemodialysis International, 2012
- Endotoxemia impairs heart mitochondrial function by decreasing electron transfer, ATP synthesis and ATP content without affecting membrane potentialJournal of Bioenergetics and Biomembranes, 2012
- Endotoxin-binding affinity of sevelamer: a potential novel anti-inflammatory mechanismKidney International, 2009
- Sevelamer Hydrochloride Use and Circulating Endotoxin in Hemodialysis Patients: A Pilot Cross-Sectional StudyJournal of Renal Nutrition, 2009
- Inflammation as a cause of malnutrition, atherosclerotic cardiovascular disease, and poor outcome in hemodialysis patientsHemodialysis International, 2004
- Endotoxin-induced myocardial dysfunction: Evidence for a role of sphingosine production*Critical Care Medicine, 2004
- Identification, characterization, and gene expression profiling of endotoxin-induced myocarditisProceedings of the National Academy of Sciences, 2003